It feels as though suddenly, everybody is injecting themselves with something—and there is nothing inherently wrong with that ...

A new FDA-approved cholesterol drug replaces injectable treatments with a daily pill—and experts say it delivers powerful ...

Strong Buy on oncology pipeline gains and LIPFENDRA launch, with KEYTRUDA patent risks. Click for this MRK update.

The FDA has approved Lipfendra, a PCSK9 inhibitor, which usually comes in the form of an injectable, in the form of a daily ...

UFC light-heavyweight Volkan Oezdemir has said he took the steroid EPO (Erythropoietin), a banned, performance-enhancing drug ...

The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.

Attorneys for an Alabama death row inmate who successfully challenged Alabama's nitrogen gas execution protocol last month ...

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase ...

MRK's Lipfendra cuts LDL-C by 59% and fills a critical gap ahead of Keytruda's 2028 patent cliff, directly challenging AMGN's Repatha injectable. UNH's Optum Rx gains negotiating leverage from the ...

Merck’s Lipfendra, the brand name for cholesterol-lowering enlicitide, will soon be available as a pill after years as an ...

The Food and Drug Administration approved a daily pill Thursday called Lipfendra, which is designed to send cholesterol ...